Jaguar Health (JAGX) Other Non-Current Liabilities (2014 - 2026)
Jaguar Health (JAGX) reported Other Non-Current Liabilities of $187000.0 for Q1 2026, down 99.49% year-over-year from $37.0 million in Q1 2025, and down 99.41% quarter-over-quarter from $31.9 million in Q4 2025.
Jaguar Health (JAGX) Other Non-Current Liabilities (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 13 years of Other Non-Current Liabilities data on file, last reported at $187000.0 in Q1 2026.
- Other Non-Current Liabilities for Q1 2026 came in at $187000.0, down 99.49% year-over-year; the trailing twelve-month figure through Mar 2026 was $187000.0 (down 99.49% YoY), and the FY2025 annual result was $31.9 million, down 9.77% from the prior year.
- Other Non-Current Liabilities declined to $187000.0 in Q1 2026 per JAGX's latest filing, from $31.9 million in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $37.0 million in Q1 2025 and troughed at $1000.0 in Q1 2022.
- A 5-year average of $24.3 million and a median of $30.9 million in 2023 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2022 and 2026: Other Non-Current Liabilities jumped 783800.0% in 2022, then plunged 99.49% in 2026.
- A 5-year view of Other Non-Current Liabilities shows it stood at $7.8 million in 2022, then soared by 294.73% to $30.9 million in 2023, then increased by 14.26% to $35.4 million in 2024, then dropped by 9.77% to $31.9 million in 2025, then plunged by 99.41% to $187000.0 in 2026.
- Business Quant data shows JAGX's Other Non-Current Liabilities at $187000.0 in Q1 2026, $31.9 million in Q4 2025, and $30.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Jaguar Health | 1.44 Mn | -10.19 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 187,000.00 |
| Dec 31, 2025 | 31.90 Mn |
| Sep 30, 2025 | 30.42 Mn |
| Jun 30, 2025 | 28.81 Mn |
| Mar 31, 2025 | 37.01 Mn |
| Dec 31, 2024 | 35.36 Mn |
| Sep 30, 2024 | 32.79 Mn |
| Mar 31, 2024 | 31.96 Mn |
| Dec 31, 2023 | 30.94 Mn |
| Dec 31, 2022 | 7.84 Mn |
| Mar 31, 2022 | 1,000.00 |
| Dec 31, 2021 | 1,000.00 |
| Sep 30, 2021 | 3,000.00 |
| Jun 30, 2021 | 7,000.00 |
| Mar 31, 2021 | 12,000.00 |
| Dec 31, 2020 | 1,000.00 |
| Sep 30, 2020 | 126,000.00 |
| Jun 30, 2020 | 4.09 Mn |
| Mar 31, 2020 | 1.25 Mn |
| Dec 31, 2019 | 1.50 Mn |